MARKET

SGP

SGP

SpyGlass Pharma, Inc.
NASDAQ
24.65
-0.21
-0.82%
Opening 11:10 08/12 EDT
OPEN
24.97
PREV CLOSE
24.85
HIGH
25.43
LOW
24.65
VOLUME
8.89K
TURNOVER
--
52 WEEK HIGH
32.44
52 WEEK LOW
17.06
MARKET CAP
824.33M
P/E (TTM)
-35.5423
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SGP last week (0803-0807)?
Weekly Report · 2d ago
SpyGlass Pharma: Buy Rating Reiterated as Late-Stage Glaucoma Pipeline Advances; $37 Price Target Maintained
TipRanks · 4d ago
SpyGlass Pharma Q2 GAAP EPS of -$0.59
Seeking Alpha · 4d ago
SpyGlass Pharma reports Q2 EPS (59c), consensus (55c)
TipRanks · 5d ago
SpyGlass Pharma, Inc. Loss At -$19.864 Mln In Q2
NASDAQ · 5d ago
Press Release: SpyGlass Pharma Reports Second -2-
Dow Jones · 5d ago
SpyGlass Pharma Insiders Enjoying US$1.1m Appreciation On US$2.16m Investment
Simply Wall St · 08/05 11:09
Weekly Report: what happened at SGP last week (0727-0731)?
Weekly Report · 08/03 10:32
More
About SGP
SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.

Webull offers SpyGlass Pharma, Inc. stock information, including NASDAQ: SGP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGP stock methods without spending real money on the virtual paper trading platform.